Featured
Read our handpicked blogs, curated for you.
|
Why the pharma marketing stack is a boardroom issue now? You might think that! Well, Indian pharma has always been…
|
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If…
|
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the…
Recent releases
|
Designing the Pharma Marketing Stack You Wish You Had in 2025
Why the pharma marketing stack is a boardroom issue now? You might think that! Well, Indian pharma has always been defined by its scale. A $50 billion industry growing at 8% annually, with some of…
|
Proving Marketing ROI to the Board with Engagement Data
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If your team is still defending budgets with vanity metrics, you lose ground.…
|
Veeva vs Modular CMS: Which Is Better for Pharma Content Approvals?
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the content approval cycle drags on for weeks, sometimes months. Every delay costs…
|
HCP Engagement Analytics & Metrics Every Pharma CMO Must Track
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to know not just if doctors were contacted, but whether those interactions drove…
